GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues

Christopher Lipina, Sarah K Walsh, Sharon E Mitchell, John R Speakman, Cherry L Wainwright, Harinder S Hundal (Corresponding Author)

Research output: Contribution to journalArticle

4 Citations (Scopus)
5 Downloads (Pure)

Abstract

Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L-α-lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.-Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.

Original languageEnglish
Pages (from-to)1299-1312
Number of pages14
JournalThe FASEB Journal
Volume33
Issue number1
Early online date27 Dec 2018
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Adiposity
G-Protein-Coupled Receptors
Insulin
Tissue
Muscle
Insulin Resistance
Skeletal Muscle
Phosphoric Monoester Hydrolases
Adipocytes
Liver
Energy Metabolism
Insulin Receptor Substrate Proteins
Adipogenesis
Endocannabinoids
Lipogenesis
Phosphorylation
Cannabinoids
Skeletal Muscle Fibers
Gene Silencing
Muscle Cells

Keywords

  • endocannabinoid
  • cannabinoid receptor
  • skeletal muscle
  • liver
  • adipogenesis
  • Endocannabinoid
  • Cannabinoid receptor
  • Liver
  • Skeletal muscle
  • Adipogenesis
  • ACTIVATION
  • STIMULATION
  • CANNABINOID RECEPTOR GPR55
  • MUSCLE
  • IDENTIFICATION
  • CARDIOMETABOLIC RISK-FACTORS
  • OBESITY
  • ENDOCANNABINOID LEVELS
  • GLUCOSE-UPTAKE
  • POTENTIAL ROLE

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Biochemistry
  • Biotechnology

Cite this

GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. / Lipina, Christopher; Walsh, Sarah K; Mitchell, Sharon E; Speakman, John R; Wainwright, Cherry L; Hundal, Harinder S (Corresponding Author).

In: The FASEB Journal, Vol. 33, No. 1, 01.01.2019, p. 1299-1312.

Research output: Contribution to journalArticle

Lipina, Christopher ; Walsh, Sarah K ; Mitchell, Sharon E ; Speakman, John R ; Wainwright, Cherry L ; Hundal, Harinder S. / GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. In: The FASEB Journal. 2019 ; Vol. 33, No. 1. pp. 1299-1312.
@article{4e76c39829374978ae7baa574c4327d7,
title = "GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues",
abstract = "Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L-α-lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.-Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.",
keywords = "endocannabinoid, cannabinoid receptor, skeletal muscle, liver, adipogenesis, Endocannabinoid, Cannabinoid receptor, Liver, Skeletal muscle, Adipogenesis, ACTIVATION, STIMULATION, CANNABINOID RECEPTOR GPR55, MUSCLE, IDENTIFICATION, CARDIOMETABOLIC RISK-FACTORS, OBESITY, ENDOCANNABINOID LEVELS, GLUCOSE-UPTAKE, POTENTIAL ROLE",
author = "Christopher Lipina and Walsh, {Sarah K} and Mitchell, {Sharon E} and Speakman, {John R} and Wainwright, {Cherry L} and Hundal, {Harinder S}",
note = "This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and Diabetes UK. The authors declare no conflicts of interest. This article includes supplemental data. Please visit http://www.fasebj.org to obtain this information.",
year = "2019",
month = "1",
day = "1",
doi = "10.1096/fj.201800171R",
language = "English",
volume = "33",
pages = "1299--1312",
journal = "The FASEB Journal",
issn = "0892-6638",
publisher = "FEDERATION AMER SOC EXP BIOL",
number = "1",

}

TY - JOUR

T1 - GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues

AU - Lipina, Christopher

AU - Walsh, Sarah K

AU - Mitchell, Sharon E

AU - Speakman, John R

AU - Wainwright, Cherry L

AU - Hundal, Harinder S

N1 - This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and Diabetes UK. The authors declare no conflicts of interest. This article includes supplemental data. Please visit http://www.fasebj.org to obtain this information.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L-α-lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.-Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.

AB - Emerging evidence indicates that G-protein coupled receptor 55 (GPR55), a nonclassic receptor of the endocannabinoid system that is activated by L-α-lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function and energy metabolism. We examined how GPR55 deficiency and modulation affects insulin signaling in skeletal muscle, adipose tissue, and liver alongside expression analysis of proteins implicated in insulin action and energy metabolism. We show that GPR55-null mice display decreased insulin sensitivity in these tissues, as evidenced by reduced phosphorylation of PKB/Akt and its downstream targets, concomitant with increased adiposity and reduced physical activity relative to wild-type counterparts. Impaired tissue insulin sensitivity coincided with reduced insulin receptor substrate-1 abundance in skeletal muscle, whereas in liver and epididymal fat it was associated with increased expression of the 3-phosphoinoistide lipid phosphatase, phosphatase and tensin homolog. In contrast, GPR55 activation enhanced insulin signaling in cultured skeletal muscle cells, adipocytes, and hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myotubes. Sustained GPR55 antagonism in 3T3-L1 adipocytes enhanced expression of proteins implicated in lipogenesis and promoted triglyceride accumulation. Our findings identify GPR55 as a positive regulator of insulin action and adipogenesis and as a potential therapeutic target for countering obesity-induced metabolic dysfunction and insulin resistance.-Lipina, C., Walsh, S. K., Mitchell, S. E., Speakman, J. R., Wainwright, C. L., Hundal, H. S. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.

KW - endocannabinoid

KW - cannabinoid receptor

KW - skeletal muscle

KW - liver

KW - adipogenesis

KW - Endocannabinoid

KW - Cannabinoid receptor

KW - Liver

KW - Skeletal muscle

KW - Adipogenesis

KW - ACTIVATION

KW - STIMULATION

KW - CANNABINOID RECEPTOR GPR55

KW - MUSCLE

KW - IDENTIFICATION

KW - CARDIOMETABOLIC RISK-FACTORS

KW - OBESITY

KW - ENDOCANNABINOID LEVELS

KW - GLUCOSE-UPTAKE

KW - POTENTIAL ROLE

UR - http://www.scopus.com/inward/record.url?scp=85059243857&partnerID=8YFLogxK

U2 - 10.1096/fj.201800171R

DO - 10.1096/fj.201800171R

M3 - Article

VL - 33

SP - 1299

EP - 1312

JO - The FASEB Journal

JF - The FASEB Journal

SN - 0892-6638

IS - 1

ER -